A Randomized, Blinded, Placebo-controlled, Phase 2 Study of INBRX-109 in Unresectable or Metastatic Conventional Chondrosarcoma

Principal Investigator

Dr Sarah Pratap

Contact us

Email: latephaseoncology@ouh.nhs.uk

IRAS number

1003996